Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Market capitalisation, EUR | 28,171 m |
| EPS, EUR | 3.87 |
| P/B ratio | 6.2 |
| P/E ratio | 59.0 |
| Dividend yield | 0.00% |
| Revenue, EUR | 4,749 m |
| Net income, EUR | 255 m |
| Profit margin | 5.37% |
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 1.76% | Equity World Health Care Social/Environmental Innovation | 8 |
| iShares Emerging Markets Equity Enhanced Active UCITS ETF USD (Acc) | 0.01% | Equity Emerging Markets Social/Environmental Multi-Asset Strategy | 1,188 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.76% | Equity United States Health Care Biotech | 46 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.76% | Equity United States Health Care Biotech | 736 |
| First Trust NYSE Arca Biotechnology UCITS ETF Acc | 3.11% | Equity United States Health Care Biotech | 10 |
| iShares Emerging Markets Equity Enhanced Active UCITS ETF (Dist) | 0.01% | Equity Emerging Markets Social/Environmental Multi-Asset Strategy | 59 |
| L&G Pharma Breakthrough UCITS ETF | 2.59% | Equity World Health Care Innovation | 16 |